Recorded Chinese product: 葡醛酸钠注射液葡醛酸钠注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司
主要成分Active Ingredients
- 葡醛酸钠Puquan Suanna
药物知识说明
葡醛酸钠是一种在国家药监局注册认定的药品。标注生产企业为徐州莱恩药业有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为:徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司、徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司、徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 葡醛酸钠注射液) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 徐州莱恩药业有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司, 徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司, 徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 葡醛酸钠注射液Recorded Chinese product: 葡醛酸钠注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 2ml:0.665g(相当于葡萄糖醛酸内酯0.5g)Recorded Chinese description: 2ml:0.665g(相当于葡萄糖醛酸内酯0.5g)
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 徐州莱恩药业有限公司Chinese legal name: 徐州莱恩药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H32026629
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H32026629
Manufacturer
Chinese legal name: 徐州莱恩药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H32026629
生产企业
徐州莱恩药业有限公司(国产)
适应症
用于急慢性肝炎和肝硬化的辅助治疗。对食物或药物中毒时的保肝及解毒有辅助作用。
用法用量
肌内注射。一次0.133~0.266kg,一日1~2次。|静脉注射。每次0.133~0.266g,一日1~2次。
不良反应
尚未发现不良反应报道。
禁忌
对本品过敏者禁用。
注意事项
1.用药期间避免阳光直射、高温及过久站立。||2.当药品形状发生改变时禁止使用。
贮藏
遮光,密闭保存。
规格
2ml:0.665g(相当于葡萄糖醛酸内酯0.5g)
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.